Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

exatecan × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Sarcoma 4 Gynecologic 2 Lymphoid 1 Genitourinary 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 625 Paclitaxel 587 Cyclophosphamide 553 Docetaxel 489 Capecitabine 437 Letrozole 371 Fulvestrant 338 Carboplatin 331 Doxorubicin 294 Tamoxifen 265 Anastrozole 232 pembrolizumab 231 Radiotherapy 218 exemestane 215 Epirubicin 208 pertuzumab 192 Bevacizumab 190 palbociclib 180 Gemcitabine 180 Vinorelbine 173 Lapatinib 164 Magnetic Resonance Spectroscopy 149 130-nm albumin-bound paclitaxel 146 eribulin 136 Albumin-Bound Paclitaxel 134 Surveys and Questionnaires 131 Exercise 129 Fluorouracil 114 Drug Therapy 113 Taxes 112

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004046 2012-05-16

Chemotherapy in Treating Women With Metastatic Breast Cancer

Daiichi Sankyo

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡